Avantor
AVTR Β· Life Sciences Tools & Services
$17.29
0.8%Mettler Toledo
MTD Β· Life Sciences Tools & Services
$1,670.29
0.9%The short version
- Avantor is the larger business, with $6.6B of revenue in fiscal 2025 against $4.0B for Mettler Toledo, about 1.6 times as much.
- Mettler Toledo grew revenue faster (4.0%, against β3.4%).
- Mettler Toledo turned more of its sales into free cash flow (21.1% FCF margin, against 7.6% FCF margin).
- Mettler Toledo earned a higher return on the capital invested in it (50.5%, against β2.1%).
| Latest fiscal year | AVTR Β· FY25 | MTD Β· FY25 |
|---|---|---|
| Size | ||
| Market cap | $11.7B | $33.7B |
| Revenue | $6.6B | $4.0B |
| Free cash flow | $495M | $849M |
| Net income | β$530M | $869M |
| Growth | ||
| Revenue growth | β3.4% | 4.0% |
| 5-year growth | 0.5% | 5.5% |
| Share count change | β0.2% | β3.0% |
| Profitability | ||
| Gross margin | 32.7% | 59.4% |
| Operating margin | β3.8% | β |
| Net margin | β8.1% | 21.6% |
| FCF margin | 7.6% | 21.1% |
| Return on capital | β2.1% | 50.5% |
| Return on equity | β9.2% | β |
| Balance sheet | ||
| Net debt | $3.6B | $2.0B |
| Net debt / EBITDA | 22.0x | 1.7x |
| Dividends and buybacks | $75.1M | $800M |
| Valuation & quality | ||
| P/E | β | 37.6x |
| Piotroski F-score | 5 | 7 |
FY16
AVTR β
MTD $2.5B
FY17
AVTR $1.2B
MTD $2.7B
FY18
AVTR $5.9B
MTD $2.9B
FY19
AVTR $6.0B
MTD $3.0B
FY20
AVTR $6.4B
MTD $3.1B
FY21
AVTR $7.4B
MTD $3.7B
FY22
AVTR $7.5B
MTD $3.9B
FY23
AVTR $7.0B
MTD $3.8B
FY24
AVTR $6.8B
MTD $3.9B
FY25
AVTR $6.6B
MTD $4.0B
AVTR
MTD
FY16
AVTR β
MTD β
FY17
AVTR β16.9%
MTD β
FY18
AVTR 7.1%
MTD β
FY19
AVTR 9.1%
MTD β
FY20
AVTR 11.1%
MTD β
FY21
AVTR 13.2%
MTD β
FY22
AVTR 15.0%
MTD β
FY23
AVTR 10.0%
MTD β
FY24
AVTR 16.0%
MTD β
FY25
AVTR β3.8%
MTD β
AVTR
MTD
FY16
AVTR β
MTD $337M
FY17
AVTR β$193M
MTD $389M
FY18
AVTR $163M
MTD $422M
FY19
AVTR $302M
MTD $506M
FY20
AVTR $868M
MTD $632M
FY21
AVTR $843M
MTD $801M
FY22
AVTR $710M
MTD $738M
FY23
AVTR $724M
MTD $861M
FY24
AVTR $692M
MTD $864M
FY25
AVTR $495M
MTD $849M
AVTR
MTD
FY16
AVTR β
MTD 36.8%
FY17
AVTR β
MTD 31.7%
FY18
AVTR β
MTD 39.2%
FY19
AVTR 9.2%
MTD 41.6%
FY20
AVTR 9.6%
MTD 43.4%
FY21
AVTR 8.1%
MTD 51.4%
FY22
AVTR 8.4%
MTD 52.6%
FY23
AVTR 5.1%
MTD 48.6%
FY24
AVTR 8.9%
MTD 55.7%
FY25
AVTR β2.1%
MTD 50.5%
AVTR
MTD
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.